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ABSTRACT: In the global world diabetes and mitochondrial disease is expected to cost the 
developing world in the next 30 years US $400 million. In diabetes an absent peripheral sink amyloid 
beta clearance pathway is now relevant to amyloid beta induced mitochondrial apoptosis. The 
quality of food consumed has raised major concerns with increased levels of plasma bacterial 
lipopolysaccharides (LPS) that induces amyloid beta aggregation and mitochondrial apoptosis with 
programmed cell death linked to non alcoholic fatty liver disease (NAFLD) and many organ 
diseases. The amount, nature and time of day of fat consumption in diabetes has become important 
with relevance to caffeine metabolism, brain toxic amyloid beta oligomer formation and neuron 
apoptosis. To prevent programmed cell death dietary fat and caffeine consumption need to be 
revised to allow rapid hepatic caffeine and amyloid beta metabolism with the prevention of global 
mitophagy associated with diabetes, NAFLD and neurodegenerative diseases. 
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INTRODUCTION  
 
Unhealthy diets, environmental influences and lifestyle changes lead to overnutrition with an excess 
of glucose, fats and proteins that enter the blood plasma and induce cell and nuclear alterations that 
lead to programmed cell death in many cells of various organs in individuals in the developing and 
developed world. Diseases such as gastrointestinal disorders, cardiovascular disease, non alcoholic 
liver disease (NAFLD), brain, thyroid, lung and diseases of the reproductive organs have increased 
in both the developing and developed world. Induction of various chronic diseases, Martins (2015) 
are associated with various cellular changes in the mitochondria (mitophagy), Vásquez-Trincado et 
al (2016), Duchen (2004), Bosch et al (2011), Nicholson (2014), Martins (2016), endoplasmic 
reticulum (ER)/golgi apparatus (ER stress/protein synthesis) and lysosomal disorders (lipid/protein 
metabolism). Insulin resistance without the hormone apelin, Martins (2015) leads to early global 
chronic disease progression and associated with inflammatory processes that alter nuclear, 
subcellular and cell membrane function that leads to cell transformation without reversible changes 
with accelerated cell aging associated with chronic diseases.     
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Healthy diets in the developed world have been encouraged to prevent mitochondrial apoptosis that 
may be induced by increased toxic amyloid beta oligomers, Manczak et al (2011), Chen and Yan 
(2006), Paganic and Eckert (2011), Chen and Yan (2007), Mossman et al (2014) that are associated 
with global chronic disease (Figure 1). Therapeutic diets in diabetes are urgently required to increase 
amyloid beta metabolism and prevent mitochondrial apoptosis that is a major defect in diabetes in 
individuals in the developed world. Healthy diets that contain unsaturated fat, fruit and fish (omega-
3) are associated with the reversal of NAFLD with the prevention of accelerated brain ageing, 
Martins (2015), Martins (2014), Martins (2016). The amount, nature of fat consumed and time of 
day of fat consumption has become important with relevance to the brain regulation of peripheral 
hepatic amyloid beta metabolism, Martins (2015). In diabetes the circadian rhythm of brain amyloid 
beta metabolism is corrupted with mitochondrial apoptosis associated with NAFLD, Martins (2015), 
Martins (2014) in these patients. Interests in the time of day (morning, afternoon, evening) of fat 
consumption in diabetes has become important that may determine cellular toxic amyloid beta 
oligomer levels and mitochondrial senescence versus apoptosis.    
 
In the developed world the amount of healthy fat consumed is between 44 and 78 gms/day in man 
http:/ Idealy How Many Grams of Fat Should You Consume Daily, (2016) and the amount is similar 
to the calcuations in mice (4.5 % diet/20-35 gms/day) for rapid hepatic fat and amyloid beta 
metabolism, Martins (2014). The healthy fat diet maintains the brain circadian rhythm (12 light/12h 
dark cycle) that is important to hepatic amyloid beta metabolism and peripheral cell mitochondrial 
function. When excess fat is consumed hepatic caffeine metabolism, Martins (2016) is delayed with 
detrimental effects on the brain circadian circuitry of peripheral amyloid beta metabolism, Martins 
(2015), Martins (2016). Caffeine can mediate its beneficial effects by the sympathetic nervous 
system, Acheson (2004) and excess transport with age may completely inactivate the apelinergic 
pathway with relevance to the autonomic nervous system, Martins (2015). The effects of delayed 
caffeine metabolism is associated with mitochondrial apoptosis, Lu et al (2008), He et al (2001), 
Dubrez et al (2001) and may be relevant to global mitochondrial disease (Figure 1) and amyloid 
beta induced mitochondrial apoptosis, Manczak et al (2011), Chen and Yan (2006), Paganic and 
Eckert (2011),  Chen and Yan (2007), Mossman et al (2014). 
 
                          
 
Figure 1.  Healthy diets in the developed and developing world that maintain the brain circadian 
rhythm (12 light/12h dark cycle) have become important to hepatic amyloid beta metabolism. 
Ingestion of excess fat delay caffeine metabolism with relevance to toxic amyloid beta oligomer 
metabolism with relevance to corruption of cell mitochondrial function. Hepatic caffeine metabolism 
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is delayed by excess fat consumption with increased transport to the brain and interference with the 
circadian rhythm and amyloid beta metabolism. 
 
Diabetes is expected to double in the next 30 years with an expected cost of US$376 million. In the 
developing world 4 out of 5 people have diabetes, www.idf.org/diabetes-burden-shifting-
developing-countries (2010), www.who.int/mediacentre/releases/ WHO | Diabetes cases could 
double in developing countries in next 30 (2003) with mitochondrial apoptosis and the major cellular 
alteration linked to many organ diseases, Martins 2015. Major concerns with relevance to food 
quality, Martins (2016) and the developing world have accelerated with the increased levels of 
bacterial lipopolysaccharides (LPS) in the plasma of developing world individuals, Martins (2016), 
Martins (2015). LPS induces amyloid beta aggregation, Martins (2015) with relevance to 
mitochondrial apoptosis and irreversible cellular changes with programmed cell death. In the 
developing world the LPS induced NAFLD delay hepatic xenobiotic and caffeine metabolism with 
relevance to accelerated peripheral tissue and brain mitochondrial apoptosis, Martins (2013). LPS 
induced NAFLD corrupt essential metabolizing cytochrome p450 enzymes that metabolize hepatic 
drug, xenobiotic and caffeine from the blood plasma and LPS may accelerate excess caffeine/drug 
transport to the brain with the aging process.    
 
In the developing world understanding the molecular cause of rapid disease progression involves the 
nucleus (anti-aging genes), Martins (2016) and the post-translational modification of proteins such 
as amyloid beta that involves LPS, Martins (2015). LPS downregulates nuclear genes (anti-aging 
genes), Martins (2016) with relevance to brain circadian regulation of amyloid beta in diabetic 
individuals in the developing world (Figure 2). Caffeine has been used to increase amyloid beta 
metabolism, Martins (2016) but increased LPS induce NAFLD relevant to mitochondrial 
dysfunction and increased caffeine levels may not be able to reverse LPS effects with increased 
glucose dyshomeostasis and mitochondrial apoptosis. LPS levels are determined by LPS binding 
protein (LBP), apo B, apo E, apo AI and phospholipid transfer protein (PLTP) levels, Martins (2016) 
Martins (2015) with relevance of these proteins in binding to LPS and to LPS neutralization, Martins 
2016, Martins (2015). The effects of increased caffeine intake are associated with 
hypercholesterolemia (high LDL levels) and low high density lipoprotein levels and effects of 
beneficial on LPS suppression may be reversed by toxic caffeine effects by caffeine 
overconsumption, Du et al (2005), Williams et al (1985), Dragicevic (2012) that leads to 
programmed cell death that involves mitochondrial apoptosis instead of mitochondrial biogenesis, 
Ding (2012), Vaughan et al (2012), Riedel et al (2012) in various tissues. 
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Figure 2. In the developing world the understanding of the cause of the diabetic epidemic has 
become of major concern to various communities. Inactivation of nuclear anti-aging genes by 
increased LPS levels in the blood plasma is associated with post-translational modifications of 
proteins (apo E, apo AI) with increased amyloid beta toxic oligomers associated with mitochondrial 
apoptosis. LPS induces NAFLD with relevance to defective caffeine metabolism in individuals from 
the developing world with increased risk for increased caffeine transport to the brain with 
neurodegneration (Type 3 diabetes).   
 
 
CONCLUSION 
 
In the developed and developing world the diabetic epidemic indicates that global mitophagy may 
be the cause of accelerated organ disease with caffeine and fat intake relevant to accelerated 
mitochondrial apoptosis in these chronic diseases. In the developed world the amount of fat 
consumed and the time of the day for consumption has now become critical to maintain hepatic 
amyloid beta metabolism and promote mitochondrial biogenesis. In the developed world caffeine 
consumption and fat intake needs to be carefully controlled to allow rapid hepatic caffeine 
metabolism without excessive caffeine transport to the brain that may induce neuron mitochondrial 
apoptosis and promote neurodegeneration. In the developing world plasma LPS levels have 
increased with the induction of NAFLD and neurodegeneration. The hepatic metabolism of fat is 
delayed in these individuals and the amount/nature of fat need to be carefully controlled to facilitate 
rapid caffeine metabolism to prevent caffeine induced mitochondrial apoptosis. Protein diet formulas 
are required to increase essential plasma proteins such as apo E, apo AI, LBP and PLTP that interact 
with LPS and prevent free LPS reactions that interfere with nuclear genes. In the absence of the 
nuclear anti-aging genes the defective nuclear-mitochondria interaction in cells of developing world 
individuals allow LPS to induce amyloid beta oligomer formation with the prevention of the caffeine 
beneficial properties but the promotion of toxic amyloid beta formation and mitochondrial apoptosis.    
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